Your browser doesn't support javascript.
loading
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.
Hayashi, Tomoya; Momota, Masatoshi; Kuroda, Etsushi; Kusakabe, Takato; Kobari, Shingo; Makisaka, Kotaro; Ohno, Yoshitaka; Suzuki, Yusuke; Nakagawa, Fumika; Lee, Michelle S J; Coban, Cevayir; Onodera, Risako; Higashi, Taishi; Motoyama, Keiichi; Ishii, Ken J; Arima, Hidetoshi.
Afiliación
  • Hayashi T; Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Momota M; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Kuroda E; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Kusakabe T; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Kobari S; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Makisaka K; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Ohno Y; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Suzuki Y; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Nakagawa F; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
  • Lee MSJ; Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Coban C; Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Onodera R; Program for Leading Graduate Schools "Health Life Science: Interdisciplinary and Global Oriented Program", Kumamoto University, Kumamoto, Japan.
  • Higashi T; Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Motoyama K; Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Ishii KJ; Laboratory of Malaria Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Arima H; Laboratory of Malaria Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Front Immunol ; 9: 2619, 2018.
Article en En | MEDLINE | ID: mdl-30515151
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra la Influenza / Linfocitos B / Infecciones por Orthomyxoviridae / Células Th2 / Células TH1 / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Límite: Animals / Female / Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra la Influenza / Linfocitos B / Infecciones por Orthomyxoviridae / Células Th2 / Células TH1 / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Límite: Animals / Female / Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza